Laura Redden

Summary

Affiliation: Abbott Laboratories
Country: USA

Publications

  1. ncbi Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder
    Laura Redden
    Abbott, Abbott Park, Illinois 60064, USA
    J Child Adolesc Psychopharmacol 19:83-9. 2009
  2. ncbi Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
    Laura Redden
    Abbott, Abbott Park, IL, USA
    Ann Gen Psychiatry 10:1. 2011
  3. ncbi A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia
    Laura Redden
    Abbott, Abbott Park, IL, USA
    J Clin Psychopharmacol 31:221-5. 2011

Detail Information

Publications3

  1. ncbi Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder
    Laura Redden
    Abbott, Abbott Park, Illinois 60064, USA
    J Child Adolesc Psychopharmacol 19:83-9. 2009
    ..The objective of this open-label study was to assess the safety of divalproex sodium extended-release in the treatment of children and adolescents with acute mania associated with bipolar I disorder...
  2. ncbi Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
    Laura Redden
    Abbott, Abbott Park, IL, USA
    Ann Gen Psychiatry 10:1. 2011
    ..abstract:..
  3. ncbi A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia
    Laura Redden
    Abbott, Abbott Park, IL, USA
    J Clin Psychopharmacol 31:221-5. 2011
    ....